Reuters logo
BRIEF-Jubilant Life Sciences arm Jubilant Pharma to explore buying specialty pharma business in U.S.
March 21, 2017 / 3:23 AM / in 9 months

BRIEF-Jubilant Life Sciences arm Jubilant Pharma to explore buying specialty pharma business in U.S.

March 21 (Reuters) - Jubilant Life Sciences Ltd:

* Board of Jubilant Pharma has approved to negotiate a potential acquisition of a specialty pharma business in U.S. Source text: bit.ly/2nMv0o8 Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below